[
  {
    "ts": null,
    "headline": "Baron Discovery Fund Q4 2025: Winners, Laggards, Buys & Sells",
    "summary": "Baron Discovery Fund Q4 2025: Winners, Laggards, Buys & Sells",
    "url": "https://finnhub.io/api/news?id=24ce4e51a32c49443b1d6e9e99c0c8ace9abd9ec6ca3c0a8bde11c1fb11db126",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771178880,
      "headline": "Baron Discovery Fund Q4 2025: Winners, Laggards, Buys & Sells",
      "id": 139108550,
      "image": "",
      "related": "ABT",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=24ce4e51a32c49443b1d6e9e99c0c8ace9abd9ec6ca3c0a8bde11c1fb11db126"
    }
  },
  {
    "ts": null,
    "headline": "Could The Market Be Wrong About Abbott Laboratories (NYSE:ABT) Given Its Attractive Financial Prospects?",
    "summary": "Abbott Laboratories (NYSE:ABT) has had a rough three months with its share price down 13%. However, stock prices are...",
    "url": "https://finnhub.io/api/news?id=6124c45a57a36b6fcc115fd6a006fc9fbd0a3d3c2c7fc1422ecad3d990414ac1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771153216,
      "headline": "Could The Market Be Wrong About Abbott Laboratories (NYSE:ABT) Given Its Attractive Financial Prospects?",
      "id": 139105952,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott Laboratories (NYSE:ABT) has had a rough three months with its share price down 13%. However, stock prices are...",
      "url": "https://finnhub.io/api/news?id=6124c45a57a36b6fcc115fd6a006fc9fbd0a3d3c2c7fc1422ecad3d990414ac1"
    }
  }
]